Untitled

[bisresearchreports]

Limited vs. Extensive Stage Small Cell Lung Cancer | BIS Research News

Lung cancer disease is characterized by an abnormal growth of the cells present in the lungs. As a result, the patient experiences basic symptoms such as shortness of breath, chest pain, and heaviness that eventually lead to the cancer cells spreading to other parts of the body

Small cell cancer types account for 10%-15% of all lung cancers and are the most aggressive type with the lowest survival rate. In contrast to SCLC in its limited stage, extensive small cell lung cancer spreads across one or both lungs.

[bisresearchreports]

Wearable Patches for Cardiovascular Care | BIS Research News

Wearable patches can measure body movement, blood pressure, and heart rate, detect and monitor arrhythmia, and support exercise training and rehabilitation.

 They are applied to the patient’s skin using adhesives to monitor the patient’s physiological signs, such as pulse. The demand for wearable patches has increased worldwide with the increase in continuous monitoring and minimum interference with body movement for the measurement of vital signs of patients and chronic diseases

[bisresearchreports]

How does Molecular Oncology Diagnostics Empower Cancer Therapies for Better Treatment?

Though the global molecular oncology diagnostics market is a well-established market, due to the continuous increase in the demand for innovative products.

Moreover, the rising prevalence of cancers and increased transformations in biomarker identification are expected to drive growth in the global molecular oncology diagnostics market.

[bisresearchreports]

Radiation Dose Management Solutions: A Key to Curb Over Exposure of Medical Radiation

Adoption of dose management software solutions is primarily expected to witness a shift from hospitals to diagnostic centers

With the growing worldwide awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing medical radiation, medical imaging companies are focused on employing dose-lowering technologies in imaging equipment. The adoption of dose management software solutions is primarily expected to witness a shift from hospitals to diagnostic centers and other end users, such as research centers and ambulatory surgical centers.

[bisresearchreports]

Can MRI-Guided Biopsy Improve Accuracy of Prostate Cancer Testing Results?

Using MRI-guided targeted biopsy or MRI-ultrasound fusion with PSA screening, it is possible to precisely pinpoint and sample suspicious tumors.

In the future, focused therapy-appropriate lesions may be targeted and followed using MRI/ultrasound fusion technologies.

[bisresearchreports]

Crucial Contribution of NGS Informatics in Automation and Optimization of Workflow

NGS informatics is a field that involves using computational and statistical methods to analyze and interpret data produced by NGS technologies.

 NGS informatics plays a key role in automating NGS workflows and improving the efficiency and reproducibility of NGS data analysis. It is expected that NGS informatics will continue to be an important field as NGS technology advances and expands in the coming years.

[bisresearchreports]

List of Essential Health Diagnostic Tests for Women in their 30s

Women's health diagnostics are important for identifying and treating health issues that are specific to women.

These tests can help detect diseases and conditions early on, when they are most treatable, which can improve outcomes and prevent serious complications.  Women's health diagnostics can also help to raise awareness about the unique health concerns and needs of women, which can help to improve access to healthcare and support services for women.

[bisresearchreports]

Acellular Therapy Market to grow at a significant CAGR. Acellular Therapy Market market report by BIS Research provides deep market insight, industry analysis, trends.

The purpose of the study is to gain a holistic view of the active acellular therapy projects implemented in several countries. The report contains the analysis of variables such as recent trends, technological advancements, and international level initiatives across the globe influencing the adoption of acellular therapy.

[bisresearchreports]

The global microbiome therapeutics market was valued at $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% from 2022-2032.

The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market.

[bisresearchreports]

The global digital PCR market is projected to reach $2,847.8 million by 2032, at a CAGR of 18.73% during the forecast period 2022-2032. The study provides an in-depth analysis of the market along with the current trends and opportunities.

The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development.

[bisresearchreports]

Can Genetic Testing Reduce the Risks of Cancer through Timely Identification?

Genetic testing is gaining significant prominence globally. Genetic testing is considered a crucial tool for the prevention of different malignancies.

Genetic testing has emerged as a crucial tool that can help people understand their genome structure and probable risks of critical diseases. For instance, cancer, which is one of the most dangerous and prominent illnesses in the modern world, is more often linked to hereditary or acquired genetic mutation.

[bisresearchreports]

The Middle East and North Africa laparoscopy devices market is anticipated to reach $1,731.4 million by 2031, witnessing a CAGR of 7.71% during the forecast period 2022-2031.

The market is driven by factors such as the rising preference for minimally invasive surgeries, increase in the prevalence of chronic diseases in the geriatric population, rising technological advancement, and increase in medical tourism in some countries.

[bisresearchreports]

The global radiation dose management market is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032.

The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation.

[bisresearchreports]

Global NIPT Market Share By Test is Dominated by Panorama and Vistara

As per BIS Research analysis, the global NIPT market was valued $2.18 billion in 2019, and is expected to reach $10.82 billion by 2030. T...

NIPT market as one of the most rapidly evolving markets amongst the other prenatal testing industries. The growth in the market is attributed to the increasing reimbursement policies and insurance coverage across the globe. Further, the continued significant investments for genome sequencing by healthcare companies to meet the industry demand and the growing incidence of genetic disorders are the prominent factors propelling the growth of the global NIPT market.

[bisresearchreports]

The global molecular oncology diagnostics market is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during forecast period 2022-2032.

The growth in the global molecular oncology diagnostics market is expected to be driven by the rising prevalence of cancers and increased transformations in biomarker identification.

[bisresearchreports]

Biomedical Segment to Continue as the Leading Application in the CRISPR Gene Editing Market

CRISPR gene editing has transformed the field of gene editing by reducing the turnaround time and complexity, enhancing accuracy, efficie...

The biomedical segment currently dominates the global CRISPR gene editing market and is anticipated to remain dominant during the forecast period 2021-2031. The dominance is attributed to the rising geriatric population, increasing prevalence of chronic diseases, and increasing investments from biopharmaceutical companies. The fastest-growing segment in biomedical is expected to be drug discovery, with a CAGR of 27.86% during the forecast period 2021-2031.

[bisresearchreports]

Oncology to be the Leading Application for the Global Epigenetics Market

Epigenetic mechanisms are being linked to a growing number of chronic diseases and disorders, including cardiovascular diseases, autoimmun...

The growth of the epigenetics market is expected to be driven by the decrease in the cost of sequencing, the global increase in the application of next-generation sequencing, and the advancement of the products. Among all applications of epigenetics, oncology accounted for the largest share in 2020, holding 52.01% of the market.